Intraoperative adenosine for pheochromocytoma with myocardial infarction and SARS-CoV-2. Case report
Abstract
Introduction: Pheochromocytomas are neuroendocrine tumors capable of synthetizing, storing and releasing catecholaminergic hormones that may lead to life-threatening hemodynamic instability. The COVID-19 pandemic has increased the risks and perioperative complexity of the patients undergoing pheochromocytoma-associated adrenalectomy. This article discusses the use of adenosine for the management of hypertensive crisis during this intervention, as well as the need to individualize the suitable timing for surgery after recent COVID-19 infection.
Case presentation: This article discusses the case of a patient with a finding of right adrenal incidentaloma; further studies determined a metanephrines secreting pheochromocytoma. Following hospital admission for preoperative optimization, the eve of the procedure the patient developed an acute myocardial infarction and subsequently SARS-CoV-2 symptomatic infection. Intraoperatively, hypertensive peaks were managed with continuous adenosine perfusion. The patient was discharged after 48 hours.
Conclusions: Preoperative optimization positively influences the intraoperative management of patients with pheochromocytoma. The intraoperative use of adenosine allows for adequate and safe control of hypertensive crises. Each situation must be individualized in patients pending surgery, with a recent COVID-19 infection.
References
Naranjo J, Dodd S, Martin Y. Perioperative management of pheocromocytoma. J Cardiothorac Vasc Anesth. 2017;31(4):1427-39. doi: https://doi.org/10.1053/j.jvca.2017.02.023.
Pisarska M, Pędziwiatr M, Budzyński A. Perioperative hemodynamic instability in patients undergoing laparoscopic adrenalectomy for pheochromocytoma. Gland Surg. 2016; 5(5):506-11. doi: https://doi.org/10.21037/gs.2016.09.05.
Neumann HPH, Young WF Jr, Eng C. Pheochromocytoma and paraganglioma. N Engl J Med. 2019;381(6):552-65. doi: https://doi.org/10.1056/NEJMra1806651
Lafont M, Fagour C, Haissaguerre M, Darancette G, Wagner T, Corcuff JB, Tabarin A. Per-operative hemodynamic instability in normotensive patients with incidentally discovered pheochromocytomas. J Clin Endocrinol Metab. 2015;100(2):417-21. doi: https://doi.org/10.1210/jc.2014-2998.
Ramakrishna H. Pheochromocytoma resection: Current concepts in anesthetic management. J Anaesthesiol Clin Pharmacol. 2015;31(3):317-23. doi: https://doi.org/10.4103/0970-9185.161665.
Cucinotta D, Vanelli M. WHO Declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157-60. doi: https://doi.org/10.23750/abm.v91i1.9397
Casey RT, Valk GD, Schalin-Jäntti C, Grossman AB, Thakker RV. Endocrinology in the time of COVID-19: Clinical management of neuroendocrine neoplasms (NENs). Eur J Endocrinol. 2020;183(2):G79-G88. doi: https://doi.org/10.1530/EJE-20-0424.
Gubbi S, Nazari MA, Taieb D, Klubo-Gwiezdzinska J, Pacak K. Catecholamine physiology and its implications in patients with COVID-19. Lancet Diabetes Endocrinol. 2020;8(12):978-86. doi: https://doi.org/10.1016/S2213-8587(20)30342-9.
COVID Surg Collaborative; GlobalSurg Collaborative. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anaesthesia. 2021. doi: https://doi.org/10.1111/anae.15458 .
Nottebaum BJ, Groeben H. Anästhesiologisches Management bei Phäochromozytomoperationen. Urologe. 2016;55:723-31. doi: https://doi.org/10.1007/s00120-016-0082-9.
Ubré M, García M, Pujol R, et al. Implicaciones anestésicas de la patología suprarrenal y cirugía de las suprarrenales y de la hipófisis. En: Gomar C, Villalonga A, Castillo J, Carrero EJ, et al. Formación continuada en anestesiología y reanimación. 1ª Edición. Madrid: Ergon; 2020. pp. 878-90.
Agencia Española del Medicamento y Productos sanitarios. Fichas técnicas de medicamentos [internet]. 2020 [citado: 2021 mar. 12]. Disponible en: https://cima.aemps.es/cima/dochtml/ft/36189/FT_36189.html
Lord MS, Augoustides JG. Perioperative management of pheochromocytoma: focus on magnesium, clevidipine, and vasopressin. J Cardiothorac Vasc Anesth. 2012;26(3):526-31. doi: https://doi.org/10.1053/j.jvca.2012.01.002.
Buch J. Urapidil, a dual-acting antihypertensive agent: Current usage considerations. Adv Ther. 2010;27(7):426-43. doi: https://doi.org/10.1007/s12325-010-0039-0.
Downloads
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
